Clinical Trial Update: Pregabalin Treatment for RDEB Pain and Itch [Phase 3]

View source ↗

Summary

Phase 3 trial of pregabalin for pain and itch in recessive dystrophic epidermolysis bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa
• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Pregabalin (Lyrica) (pregabalin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Pain, Neuropathic, Itch | Phase 3 | Status: COMPLETED